camptothecin has been researched along with 1-anilino-8-naphthalenesulfonate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, M; Xie, M; Xue, B; Yan, B; Yang, D | 1 |
| Bettegowda, C; Cheong, I; Diaz, LA; Huang, X; Kinzler, KW; Vogelstein, B; Zhou, S | 1 |
| Gu, Z; Liao, C; Pang, J; Wu, F; Zhang, S | 1 |
3 other study(ies) available for camptothecin and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Mouse liver and kidney carboxylesterase (M-LK) rapidly hydrolyzes antitumor prodrug irinotecan and the N-terminal three quarter sequence determines substrate selectivity.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carboxylesterase; Carboxylic Ester Hydrolases; Humans; Hydrolysis; Irinotecan; Kidney; Lipase; Liver; Mice; Molecular Sequence Data; Peptide Fragments; Prodrugs; Sequence Homology, Amino Acid; Substrate Specificity | 2003 |
A bacterial protein enhances the release and efficacy of liposomal cancer drugs.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Bacterial Proteins; Base Sequence; Camptothecin; Cell Line, Tumor; Cloning, Molecular; Clostridium; Colorectal Neoplasms; Doxorubicin; Drug Carriers; Humans; Irinotecan; Lipase; Lipid Bilayers; Liposomes; Mice; Molecular Sequence Data; Mutation; Neoplasm Transplantation; Protein Structure, Tertiary | 2006 |
Terminal Acetylated/Acrylated Poly(ethylene glycol) Fabricated Drug Carriers: Design, Synthesis, and Biological Evaluation.
Topics: A549 Cells; Acetylation; Acrylates; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Survival; Drug Carriers; Drug Compounding; Drug Liberation; Female; Flocculation; Fungal Proteins; Humans; Hydrogen Bonding; Irinotecan; Kinetics; Lipase; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Polyethylene Glycols; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |